Our results showed that intranasal insulin could improve cognitive deficits in ICV-STZ rats, which may be associated with reduced tau hyperphosphorylation, ameliorated activation of microglia and increased neurogenesis. This evidence concerns the gene MAPT and Cognitive impairment.